Brent Ristow, CEO of Brighton Ashford, leverages his legal and scientific expertise to ensure FDA compliance for pharmaceuticals and medical devices. With a background in law and a Ph.D. in Organic Photochemistry, Brent Ristow's company delivers meticulous testing conforming to Title 21 standards and cGMP guidelines. Trusted by Fortune 500 firms and startups alike, Brighton Ashford exceeds regulatory expectations under Ristow's leadership.
https://www.brightonashford.com